On April 5, the federal health institution of Canada authorized the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age. This is the first COVID-19 vaccine authorized in Canada for use in children and marks a significant milestone in Canada's fight against the COVID-19 pandemic, as reported on the website of the department.
Health Canada studied the Pfizer vaccine and determined that it was effective and safe for children aged 12-15 years.
“After completing a thorough and independent scientific review of the evidence, the Department has determined that this vaccine is safe and effective at preventing COVID-19 when used in children between 12 and 15 years of age,” the statement says.
Health Canada has issued this permit on the condition that Pfizer will continue to provide the agency with information on the safety, efficacy and quality of the vaccine in this younger age group.
As it was reported earlier, the U.S. government is about to allow the use of vaccine from Pfizer company to inoculate children aged from 12 to 15. The vaccination will begin already next week. Approval is expected after the drug manufacturers announced the safety and effectiveness of the vaccine in March, and it elicited a sustained antibody response in children aged 12 to 15 years in clinical trials.